MarcelVan Den BrinkMDPhD

Hematologic Oncology

President of City of Hope Los Angeles and National Medical Center

Dr. Van Den Brink is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
City of Hope (Duarte)
1500 East Duarte Road
Duarte, CA 91010
Phone+1 626-218-4328

Dr. Marcel Van Den Brink is the President of City of Hope Los Angeles and National Medical Center
and Chief Physician Executive. He received his medical degree from Leiden University Faculty of Medicine and has been in practice 31 years. He specializes in hematologic oncology and is experienced in hematologic oncology.

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1999
Duke University HospitalResidency, Internal Medicine, 1991 - 1993
Leiden University Faculty of MedicineClass of 1986

PubMed

56 citations
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
Il-Kang Na, Sydney X. Lu, Nury L. Yim, Gabrielle L. Goldberg, Jennifer Tsai
The Journal of Clinical Investigation. 2010-01-04
271 citations
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Tri...
Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia
Biology of Blood and Marrow Transplantation. 2017-02-01
76 citations
RIG-I activation is critical for responsiveness to checkpoint blockade.
Simon Heidegger, Alexander Wintges, Florian Stritzke, Sarah Bek, Katja Steiger
Science Immunology. 2019-09-13

Lectures

Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Expression of the Butyrate/Niacin Receptor, GPR109a on T Cells Plays an Important Role in a Mouse Model of Graft Versus Host Disease
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018